These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1698719)

  • 1. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
    Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of hydroxyethyl-starch on hemorheology in patients with chronic liver disease].
    Lao JX; Gu MN; Xiao JF; Lu XM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):438-40. PubMed ID: 15837650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
    Kortsik CS; Staedt U; Stein T; Geiger G; Buss J
    Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on isovolemic hemodilution in acute ischemic stroke.
    Comes L; Mureşan A; Costin Z
    Rom J Intern Med; 1996; 34(1-2):43-7. PubMed ID: 8908629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
    Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.